TippingPoint Biosciences
PrivateLast Round
Seed
Mar 31, 2026
Total Funding Raised
$7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TippingPoint Biosciences operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in March 2026.
TippingPoint Biosciences is a biotechnology company that operates a drug discovery platform intended to identify treatments for diseases caused by defects in DNA packaging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TippingPoint Biosciences Comparables
Compare TippingPoint Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altay Therapeutics | 81% | |
| Moonwalk Biosciences | 76% | |
| Foghorn Therapeutics | 69% |
For institutional investors. Book with your work email.
TippingPoint Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 31, 2026 | ||||
| Pre Seed | Sep 4, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TippingPoint Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuvaan Tiwari Foundation | Pre Seed |
| Freeflow Ventures | Seed |
| WECAN Capital Partners | Seed |
| The Sontag Foundation | Pre Seed, Seed |
| BrightEdge | Pre Seed, Seed |
| Mission BioCapital | Pre Seed |
| Pediatric Brain Tumor Foundation | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 992% MoM.
- Apr 6, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
TippingPoint Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TippingPoint Biosciences's valuation, stock price, and market status.
Is TippingPoint Biosciences a public or private company?
TippingPoint Biosciences is a private company.
What is the current stock price of TippingPoint Biosciences?
TippingPoint Biosciences is a private company, so its shares have no public market price. Caplight tracks TippingPoint Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TippingPoint Biosciences worth (valuation)?
Valuation information for TippingPoint Biosciences is not publicly available.
Can I buy TippingPoint Biosciences stock?
TippingPoint Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TippingPoint Biosciences's last funding round?
TippingPoint Biosciences's most recent funding round was Seed on March 31, 2026.
Who are the main investors in TippingPoint Biosciences?
Key investors in TippingPoint Biosciences include SOSV.
Will TippingPoint Biosciences IPO soon?
No public IPO plans have been announced for TippingPoint Biosciences.
How can I track TippingPoint Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in TippingPoint Biosciences's shares on secondary markets.